Penumbra Inc
(STU:0P8)
€
212.2
2.5 (1.19%)
Market Cap: 8.20 Bil
Enterprise Value: 8.14 Bil
PE Ratio: 266.87
PB Ratio: 7.97
GF Score: 87/100 
Penumbra Inc at Wells Fargo Healthcare Conference Transcript
Sep 04, 2019 / 07:00PM GMT
Release Date Price:
€129.2
(-2.31%)
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Analyst
All right. Good afternoon, everyone. I'm Larry Biegelsen, the medical device analyst at Wells Fargo. And it's my pleasure to host this session with the management team of Penumbra. With us, we have Adam Elsesser, the CEO; and Sri Kosaraju, who is the new President, I believe? I don't know if it's official yet, but recently promoted.
Sridhar N. Kosaraju
Penumbra, Inc. - President & CFO
Yes, yes.
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Analyst
And Chief Financial Officer. The format is fireside chat. If anybody in the audience has a question, please raise your hand.
Questions & Answers
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Analyst
So Adam and Sri, thank you very much for being with us.
Sridhar N. Kosaraju
Penumbra, Inc. - President & CFO
Yes.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers